| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium berghei | 54 | 2022 | 159 | 9.750 |
Why?
|
| Malaria | 75 | 2023 | 1226 | 8.210 |
Why?
|
| Plasmodium | 39 | 2023 | 247 | 7.900 |
Why?
|
| Sporozoites | 31 | 2020 | 82 | 4.350 |
Why?
|
| Host-Parasite Interactions | 24 | 2022 | 301 | 4.340 |
Why?
|
| Hepatocytes | 38 | 2022 | 1230 | 4.210 |
Why?
|
| Parasites | 8 | 2023 | 161 | 3.410 |
Why?
|
| Protozoan Proteins | 20 | 2023 | 839 | 2.690 |
Why?
|
| Antimalarials | 30 | 2022 | 905 | 2.590 |
Why?
|
| Liver | 46 | 2023 | 7502 | 2.390 |
Why?
|
| Plasmodium falciparum | 27 | 2022 | 1742 | 1.900 |
Why?
|
| Malaria, Cerebral | 6 | 2023 | 136 | 1.400 |
Why?
|
| Vacuoles | 7 | 2017 | 228 | 1.400 |
Why?
|
| Phosphotransferases | 3 | 2023 | 302 | 1.030 |
Why?
|
| Antigens, Protozoan | 8 | 2015 | 316 | 0.920 |
Why?
|
| Erythrocytes | 17 | 2023 | 2413 | 0.900 |
Why?
|
| Plasmodium yoelii | 9 | 2010 | 42 | 0.800 |
Why?
|
| Toxoplasma | 3 | 2018 | 151 | 0.790 |
Why?
|
| Mice, Inbred C57BL | 35 | 2023 | 22003 | 0.750 |
Why?
|
| Animals | 104 | 2023 | 167768 | 0.720 |
Why?
|
| Membrane Proteins | 6 | 2020 | 7843 | 0.690 |
Why?
|
| Hep G2 Cells | 7 | 2017 | 378 | 0.650 |
Why?
|
| Erythropoiesis | 1 | 2023 | 682 | 0.640 |
Why?
|
| Life Cycle Stages | 10 | 2022 | 160 | 0.640 |
Why?
|
| Mice | 65 | 2023 | 81101 | 0.630 |
Why?
|
| Malaria, Falciparum | 6 | 2018 | 1076 | 0.620 |
Why?
|
| Mice, Inbred BALB C | 18 | 2020 | 6209 | 0.620 |
Why?
|
| Amino Acids | 1 | 2023 | 1713 | 0.550 |
Why?
|
| Heme Oxygenase-1 | 3 | 2011 | 363 | 0.520 |
Why?
|
| Autophagy | 3 | 2020 | 1322 | 0.510 |
Why?
|
| Parasitic Diseases | 1 | 2015 | 76 | 0.490 |
Why?
|
| Phosphatidylcholines | 2 | 2023 | 405 | 0.480 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2015 | 119 | 0.480 |
Why?
|
| Host-Pathogen Interactions | 4 | 2017 | 1444 | 0.470 |
Why?
|
| Unfolded Protein Response | 1 | 2015 | 232 | 0.430 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2017 | 1074 | 0.430 |
Why?
|
| Naphthyridines | 1 | 2013 | 138 | 0.410 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 341 | 0.400 |
Why?
|
| Anopheles | 6 | 2018 | 192 | 0.390 |
Why?
|
| Superinfection | 1 | 2011 | 64 | 0.370 |
Why?
|
| Carbon Monoxide | 3 | 2011 | 540 | 0.370 |
Why?
|
| Flow Cytometry | 7 | 2013 | 5864 | 0.370 |
Why?
|
| Cell Line | 13 | 2020 | 15591 | 0.350 |
Why?
|
| Acute Lung Injury | 2 | 2011 | 367 | 0.350 |
Why?
|
| Interferon Type I | 1 | 2013 | 559 | 0.340 |
Why?
|
| Mitosis | 1 | 2014 | 1191 | 0.330 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2008 | 84 | 0.330 |
Why?
|
| Iron | 2 | 2022 | 1786 | 0.310 |
Why?
|
| Amino Acyl-tRNA Synthetases | 2 | 2022 | 88 | 0.310 |
Why?
|
| Genistein | 1 | 2008 | 86 | 0.310 |
Why?
|
| Microscopy | 2 | 2013 | 884 | 0.310 |
Why?
|
| Parasitemia | 5 | 2017 | 166 | 0.300 |
Why?
|
| Cell Movement | 2 | 2013 | 5201 | 0.290 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2009 | 778 | 0.290 |
Why?
|
| Liver Diseases | 3 | 2017 | 1296 | 0.290 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2009 | 311 | 0.290 |
Why?
|
| Immunity, Innate | 5 | 2015 | 3047 | 0.290 |
Why?
|
| Locomotion | 1 | 2009 | 387 | 0.280 |
Why?
|
| Bacterial Infections | 1 | 2015 | 1401 | 0.280 |
Why?
|
| Azepines | 1 | 2009 | 329 | 0.280 |
Why?
|
| Protein Multimerization | 1 | 2012 | 979 | 0.270 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 52 | 0.270 |
Why?
|
| Alanine | 1 | 2009 | 603 | 0.270 |
Why?
|
| Green Fluorescent Proteins | 9 | 2015 | 2057 | 0.270 |
Why?
|
| Actins | 2 | 2012 | 2049 | 0.270 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 9404 | 0.260 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 18119 | 0.250 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 754 | 0.250 |
Why?
|
| Heme | 1 | 2007 | 313 | 0.250 |
Why?
|
| Malaria Vaccines | 4 | 2008 | 164 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 11892 | 0.240 |
Why?
|
| GTP Phosphohydrolases | 2 | 2022 | 517 | 0.230 |
Why?
|
| Protein Kinases | 2 | 2014 | 1610 | 0.230 |
Why?
|
| Hemeproteins | 3 | 2013 | 61 | 0.230 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1199 | 0.230 |
Why?
|
| Imines | 2 | 2013 | 27 | 0.220 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1894 | 0.220 |
Why?
|
| Luciferases | 3 | 2014 | 714 | 0.210 |
Why?
|
| eIF-2 Kinase | 1 | 2023 | 144 | 0.200 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2003 | 267 | 0.200 |
Why?
|
| Mammals | 3 | 2023 | 1132 | 0.190 |
Why?
|
| Oocysts | 2 | 2018 | 16 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2023 | 345 | 0.180 |
Why?
|
| Transformation, Genetic | 1 | 2001 | 192 | 0.180 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 3432 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1600 | 0.180 |
Why?
|
| Humans | 69 | 2023 | 758406 | 0.180 |
Why?
|
| Drug Resistance | 6 | 2015 | 1593 | 0.180 |
Why?
|
| Quinolones | 2 | 2013 | 377 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4567 | 0.170 |
Why?
|
| Microarray Analysis | 2 | 2013 | 746 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2003 | 567 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2020 | 3090 | 0.170 |
Why?
|
| Virulence | 2 | 2017 | 1298 | 0.170 |
Why?
|
| Cells, Cultured | 10 | 2020 | 18940 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3480 | 0.160 |
Why?
|
| Plasmodium vivax | 3 | 2015 | 202 | 0.160 |
Why?
|
| Trypanosoma | 1 | 2018 | 16 | 0.160 |
Why?
|
| Models, Molecular | 6 | 2017 | 5410 | 0.160 |
Why?
|
| Quinazolinones | 2 | 2022 | 221 | 0.160 |
Why?
|
| Protein Binding | 3 | 2020 | 9311 | 0.150 |
Why?
|
| Transfection | 3 | 2006 | 5779 | 0.150 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 2850 | 0.150 |
Why?
|
| Endocytosis | 1 | 2022 | 958 | 0.150 |
Why?
|
| Digestive System | 1 | 2018 | 244 | 0.150 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2015 | 36 | 0.150 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 147 | 0.150 |
Why?
|
| Signal Transduction | 5 | 2015 | 23342 | 0.150 |
Why?
|
| Coculture Techniques | 3 | 2016 | 1339 | 0.140 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2017 | 28 | 0.140 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2017 | 94 | 0.140 |
Why?
|
| Primaquine | 2 | 2019 | 28 | 0.140 |
Why?
|
| Sickle Cell Trait | 1 | 2017 | 85 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2023 | 908 | 0.140 |
Why?
|
| Luteolin | 1 | 2016 | 13 | 0.140 |
Why?
|
| Palmitic Acids | 1 | 2016 | 52 | 0.140 |
Why?
|
| Culicidae | 3 | 2011 | 108 | 0.140 |
Why?
|
| Quinolines | 2 | 2013 | 759 | 0.140 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 555 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2017 | 261 | 0.130 |
Why?
|
| Plasmodium chabaudi | 2 | 2010 | 19 | 0.130 |
Why?
|
| Male | 21 | 2020 | 358747 | 0.130 |
Why?
|
| Protein Conformation | 3 | 2020 | 3966 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 2470 | 0.130 |
Why?
|
| Ethanolamines | 1 | 2016 | 153 | 0.130 |
Why?
|
| Structure-Activity Relationship | 7 | 2015 | 3069 | 0.130 |
Why?
|
| Genome, Human | 1 | 2008 | 4416 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 296 | 0.120 |
Why?
|
| Protein Transport | 1 | 2020 | 1963 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 1172 | 0.120 |
Why?
|
| Fatty Acids | 2 | 2022 | 1803 | 0.120 |
Why?
|
| Exocytosis | 2 | 2008 | 319 | 0.110 |
Why?
|
| Parasitic Sensitivity Tests | 4 | 2019 | 88 | 0.110 |
Why?
|
| Flavones | 1 | 2013 | 67 | 0.110 |
Why?
|
| Seaweed | 1 | 2013 | 28 | 0.110 |
Why?
|
| Parasitology | 1 | 2013 | 28 | 0.110 |
Why?
|
| Genome, Protozoan | 1 | 2014 | 148 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4257 | 0.110 |
Why?
|
| Oligonucleotides | 2 | 2013 | 582 | 0.110 |
Why?
|
| Pyrimethamine | 4 | 2011 | 94 | 0.110 |
Why?
|
| Cell Line, Tumor | 11 | 2016 | 16886 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 597 | 0.110 |
Why?
|
| Mice, Inbred DBA | 2 | 2011 | 622 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 141 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2019 | 1335 | 0.100 |
Why?
|
| Artemisinins | 2 | 2011 | 218 | 0.100 |
Why?
|
| Thiogalactosides | 1 | 2011 | 7 | 0.100 |
Why?
|
| Genes, Protozoan | 3 | 2022 | 166 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2015 | 520 | 0.100 |
Why?
|
| Organisms, Genetically Modified | 1 | 2012 | 63 | 0.100 |
Why?
|
| Skin | 2 | 2008 | 4464 | 0.100 |
Why?
|
| Plasmodium malariae | 1 | 2011 | 13 | 0.100 |
Why?
|
| Metformin | 1 | 2019 | 907 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2023 | 8297 | 0.100 |
Why?
|
| Piperidines | 2 | 2022 | 1639 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2379 | 0.100 |
Why?
|
| Blood | 1 | 2014 | 586 | 0.100 |
Why?
|
| Indole Alkaloids | 1 | 2011 | 23 | 0.090 |
Why?
|
| Gelsolin | 1 | 2012 | 189 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 540 | 0.090 |
Why?
|
| Toxoplasmosis | 1 | 2011 | 93 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 383 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 462 | 0.090 |
Why?
|
| Cell Shape | 1 | 2011 | 371 | 0.090 |
Why?
|
| Mefloquine | 3 | 2019 | 55 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11471 | 0.090 |
Why?
|
| Chloroquine | 4 | 2013 | 274 | 0.090 |
Why?
|
| Arginase | 1 | 2010 | 80 | 0.090 |
Why?
|
| Glucose | 3 | 2017 | 4336 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2013 | 489 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 726 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2018 | 1607 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2015 | 14354 | 0.080 |
Why?
|
| Salivary Glands | 1 | 2011 | 229 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 955 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2129 | 0.080 |
Why?
|
| Antioxidants | 1 | 2017 | 1662 | 0.080 |
Why?
|
| Lung | 3 | 2022 | 9985 | 0.080 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2011 | 436 | 0.080 |
Why?
|
| Anions | 1 | 2009 | 137 | 0.080 |
Why?
|
| Pneumocystis carinii | 1 | 2009 | 72 | 0.080 |
Why?
|
| Mast Cells | 1 | 2016 | 1390 | 0.080 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 354 | 0.080 |
Why?
|
| Quinazolines | 1 | 2015 | 1360 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2015 | 1333 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2015 | 1527 | 0.080 |
Why?
|
| Proteomics | 2 | 2015 | 3816 | 0.080 |
Why?
|
| Primates | 1 | 2011 | 523 | 0.080 |
Why?
|
| Macrophages | 2 | 2017 | 5737 | 0.080 |
Why?
|
| Tubulin | 1 | 2012 | 692 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 648 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 219 | 0.080 |
Why?
|
| Gold | 1 | 2011 | 479 | 0.070 |
Why?
|
| Kinetics | 2 | 2013 | 6371 | 0.070 |
Why?
|
| Animals, Genetically Modified | 4 | 2017 | 1553 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 575 | 0.070 |
Why?
|
| Pulmonary Circulation | 1 | 2010 | 743 | 0.070 |
Why?
|
| DNA Primers | 2 | 2009 | 2816 | 0.070 |
Why?
|
| Mitochondria | 2 | 2018 | 3584 | 0.070 |
Why?
|
| RNA, Protozoan | 1 | 2006 | 45 | 0.070 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2006 | 57 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3709 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2895 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 933 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3801 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2017 | 3099 | 0.070 |
Why?
|
| Drug Design | 2 | 2015 | 1049 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3299 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2007 | 240 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2013 | 5031 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1895 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2868 | 0.070 |
Why?
|
| Globins | 1 | 2007 | 403 | 0.070 |
Why?
|
| Chimera | 1 | 2007 | 452 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2014 | 2907 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2013 | 3680 | 0.060 |
Why?
|
| Thymidylate Synthase | 2 | 2006 | 74 | 0.060 |
Why?
|
| Dendritic Cells | 3 | 2007 | 2723 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2013 | 2292 | 0.060 |
Why?
|
| Blood Group Antigens | 1 | 2007 | 187 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2008 | 1507 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1664 | 0.060 |
Why?
|
| Molecular Structure | 3 | 2015 | 1866 | 0.060 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 2006 | 133 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2010 | 661 | 0.060 |
Why?
|
| Rats | 3 | 2017 | 23679 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2796 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9518 | 0.060 |
Why?
|
| Cell Survival | 1 | 2014 | 5781 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6068 | 0.060 |
Why?
|
| Ion Channels | 1 | 2009 | 1043 | 0.060 |
Why?
|
| Phagocytosis | 2 | 2007 | 1533 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2004 | 835 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1455 | 0.060 |
Why?
|
| Imidazoles | 1 | 2009 | 1179 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2023 | 73 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1842 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1972 | 0.050 |
Why?
|
| Biological Transport | 1 | 2007 | 2084 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2006 | 1991 | 0.050 |
Why?
|
| Leukocytes | 1 | 2011 | 2025 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2007 | 1955 | 0.050 |
Why?
|
| Immunization | 1 | 2007 | 1227 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3047 | 0.050 |
Why?
|
| Dyspnea | 1 | 2010 | 1344 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 88 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2007 | 2626 | 0.050 |
Why?
|
| Movement | 2 | 2008 | 1474 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 964 | 0.050 |
Why?
|
| Genotype | 1 | 2016 | 12945 | 0.050 |
Why?
|
| Apoptosis | 3 | 2005 | 9468 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3774 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1793 | 0.040 |
Why?
|
| Luminescence | 2 | 2011 | 108 | 0.040 |
Why?
|
| Methylation | 1 | 2023 | 1080 | 0.040 |
Why?
|
| Plasmids | 2 | 2006 | 2275 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2015 | 5070 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2022 | 289 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11070 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2011 | 1940 | 0.040 |
Why?
|
| Base Sequence | 2 | 2009 | 12436 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4624 | 0.040 |
Why?
|
| Phospholipids | 1 | 2023 | 784 | 0.040 |
Why?
|
| Myosins | 1 | 2001 | 405 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2008 | 4113 | 0.040 |
Why?
|
| Subtilisin | 1 | 2018 | 12 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 10748 | 0.040 |
Why?
|
| Lipase | 1 | 2020 | 324 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9574 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 837 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2019 | 231 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 665 | 0.040 |
Why?
|
| Trypanosomiasis, African | 1 | 2016 | 30 | 0.040 |
Why?
|
| Vaccination | 2 | 2006 | 3355 | 0.040 |
Why?
|
| Neurons | 1 | 2016 | 9416 | 0.030 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2016 | 45 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 5629 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1759 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12094 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2016 | 276 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2008 | 3387 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2016 | 410 | 0.030 |
Why?
|
| Gene Expression | 1 | 2008 | 7583 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2017 | 472 | 0.030 |
Why?
|
| Chagas Disease | 1 | 2016 | 167 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 15785 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2001 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 206 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 2212 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2015 | 112 | 0.030 |
Why?
|
| Female | 8 | 2017 | 390323 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13468 | 0.030 |
Why?
|
| Time Factors | 3 | 2015 | 39872 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
| Vaccines, Attenuated | 2 | 2005 | 314 | 0.030 |
Why?
|
| Electron Transport Complex III | 1 | 2013 | 31 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2013 | 245 | 0.030 |
Why?
|
| Amides | 1 | 2016 | 447 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2013 | 173 | 0.030 |
Why?
|
| Oxygen | 2 | 2016 | 4191 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2001 | 2666 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 298 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6127 | 0.030 |
Why?
|
| Histones | 1 | 2023 | 2577 | 0.030 |
Why?
|
| Bioethics | 1 | 2014 | 117 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 613 | 0.030 |
Why?
|
| Decoquinate | 1 | 2012 | 3 | 0.030 |
Why?
|
| Crystallization | 1 | 2013 | 533 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1492 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2011 | 2176 | 0.030 |
Why?
|
| Atovaquone | 1 | 2012 | 56 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 2011 | 80 | 0.020 |
Why?
|
| Cytokines | 1 | 2007 | 7338 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 17617 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 454 | 0.020 |
Why?
|
| Insect Vectors | 1 | 2012 | 134 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2011 | 175 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2938 | 0.020 |
Why?
|
| Quinine | 1 | 2011 | 51 | 0.020 |
Why?
|
| Hemin | 1 | 2011 | 50 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2011 | 247 | 0.020 |
Why?
|
| Animal Experimentation | 1 | 2011 | 46 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2011 | 157 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3593 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2011 | 189 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1134 | 0.020 |
Why?
|
| Hepatitis B | 1 | 2015 | 701 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 611 | 0.020 |
Why?
|
| Vero Cells | 1 | 2011 | 482 | 0.020 |
Why?
|
| Adipocytes | 1 | 2016 | 1177 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3754 | 0.020 |
Why?
|
| Nitrobenzoates | 1 | 2009 | 16 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2009 | 508 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6293 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2904 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 13447 | 0.020 |
Why?
|
| Chlorine | 1 | 2009 | 57 | 0.020 |
Why?
|
| Drug Stability | 1 | 2009 | 290 | 0.020 |
Why?
|
| Clomiphene | 1 | 2009 | 71 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 397 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6520 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 724 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2022 | 7590 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 17768 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2011 | 856 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2011 | 552 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2836 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 548 | 0.020 |
Why?
|
| Binding Sites | 1 | 2017 | 6036 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2015 | 1353 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 16534 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2011 | 559 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 623 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1593 | 0.020 |
Why?
|
| Uracil | 1 | 2008 | 207 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 3258 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3156 | 0.020 |
Why?
|
| Cysteine | 1 | 2011 | 893 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14641 | 0.020 |
Why?
|
| Brain | 2 | 2010 | 26947 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 1974 | 0.020 |
Why?
|
| Models, Biological | 1 | 2002 | 9460 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2015 | 1579 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2015 | 4087 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2005 | 777 | 0.020 |
Why?
|
| Proteins | 2 | 2015 | 6026 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 4313 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2009 | 963 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2872 | 0.010 |
Why?
|
| Electroporation | 1 | 2006 | 254 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2009 | 557 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2010 | 1018 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2005 | 223 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1897 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2011 | 1044 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4549 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 728 | 0.010 |
Why?
|
| Zebrafish | 1 | 2014 | 2993 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2005 | 368 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 876 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3502 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 174 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 123 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 42062 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 2825 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4938 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 532 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10112 | 0.010 |
Why?
|
| Longevity | 1 | 2008 | 1050 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2003 | 583 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1203 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 2100 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 929 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2005 | 933 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 911 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2646 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 829 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2002 | 1218 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 1174 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2003 | 1254 | 0.010 |
Why?
|
| Indoles | 1 | 2005 | 1828 | 0.010 |
Why?
|
| DNA | 1 | 2011 | 7199 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 1020 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 1411 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 3380 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3526 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9160 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5779 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2003 | 2297 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 12759 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 64378 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5490 | 0.010 |
Why?
|